Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease.
Christopher MaJeffrey K LeeAnish R MitraAnouar TeriakyDaksh ChoudharyTran M NguyenNiels Vande CasteeleReena KhannaRemo PanaccioneBrian G FeaganVipul JairathPublished in: Alimentary pharmacology & therapeutics (2019)
JAK inhibitors are effective for inducing clinical remission in CD and induction of clinical and endoscopic remission in UC, although are associated with an increased risk of infectious complications.